Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’ Sophie Chan[email protected]9 February 2024ProfileLife Sciences Yearbook 2024 Baker McKenzie’s Jaspreet Takhar on the future of digital health solutionsWhat made you decide to specialise in life sciences law? Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryM&A perspectives: Melissa FogartyM&A perspectives: Jennifer BethlehemM&A perspectives: Lorenzo CorteSponsored thought leadership: China life sciences – Transaction insights and notable industry trendsThe Legal 500 view: Healthy competitionLife Sciences Yearbook 2024 – Editor’s letterTransatlantic firms outstrip peers on five-year PEP growth, LB100 data revealsA good time to be mid-tier: private equity interest on the rise as mid-market thrivesThe LB100 ranked by PEP: firms push partner profits to new heights as associate pay debate rumbles on